Jason Mills
Head of US Healthcare Research at Canaccord Genuity

Jason Mills has been a publishing sell-side analyst with coverage of medical devices for over 15 years. In addition to serving as Head of US Healthcare Research at Canaccord Genuity, Mr. Mills’s specific research coverage focus is on the sectors of Cardiovascular, Imaging/Robotics, Ophthalmology and Women’s Healthcare. Mr. Mills joined Canaccord Genuity as Managing Director and Senior Medical Devices analyst in 2007, coming to the firm from First Albany Capital where he was managing director and senior medical devices analyst since 2003. He had previously served as a vice president and senior med-tech analyst with Thomas Weisel Partners (now part of Stifel), Mr. Mills has earned awards for his stock picking, including the #2 ranked Medical Devices analyst in the The Wall Street Journal’s 2011 ‘Best on the Street’ Survey and #1 in the Medical Products segment of Forbes 2010 Best Brokerage Analysts. Mr. Mills holds a BA in Economics from Yale University and Master degree from Ohio University. Mr. Mills is currently acting as Treasurer for the Luena Foundation.